Purchase Order 36C26026P0103
- Not listed
- Novocure Inc. was awarded a $49,748.73 firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 7 on November 5, 2025, for Optune Plus transducers. The contract, which carries no set-aside designation, is scheduled for completion by February 27, 2026, and will be performed in Portsmouth, New Hampshire. This award represents a delivery order under Novocure's existing Federal Supply Schedule contract with the VA Veterans Health Administration for...
- Novocure Inc. was awarded a firm fixed-price purchase order valued at $49,748.73 by the Department of Veterans Affairs' Veterans Integrated Service Network 20 (VISN 20) on November 13, 2025, for Optune Plus transducers. The contract, which carries an ultimate completion date of November 12, 2026, will be performed in Portsmouth, New Hampshire. This award represents delivery of specialized medical device components under Novocure's existing Federal Supply Schedule contract with the VA Veterans...
- Novocure Inc. was awarded a delivery order valued at $49,748.73 for Optune Plus transducers by the Department of Veterans Affairs' Veterans Integrated Service Network 10, with an ultimate completion date of January 20, 2026. The award, issued on October 20, 2025, operates under a firm fixed-price contract structure with no set-aside designation. The delivery order stems from Novocure's broader General Services Administration Federal Supply Schedule contract for Medical Equipment and Supplies...
- Novocure Inc. has been awarded a $49,748.73 firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 to provide transducers and related equipment rentals and services. As the prime contractor, Novocure will deliver its Optune tumor treating fields therapy devices, transducer arrays, and support directly to the VA medical center located in Portsmouth, New Hampshire. Additionally, Novocure holds a five-year, $28.85...
- Novocure Inc. has been awarded a firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7. The contract is for $49,748.73 to provide Optune Plus Transducers with no set-aside designation. As the prime contractor, Novocure will deliver its Optune tumor treating fields therapy devices and transducer arrays directly to the VA medical center located in Portsmouth, New Hampshire by May 31, 2024. Additionally, Novocure...
- Novocure Inc. has been awarded a firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 for $49,748.73. Under this contract, Novocure will provide its Optune tumor treating fields therapy delivery systems, transducer arrays, and related equipment rentals and services directly to the VA medical center located in Portsmouth, New Hampshire. As the prime contractor, Novocure will be responsible for delivering...
- The Department of Veterans Affairs, Veterans Integrated Service Network 15 (VISN 15), awarded a $49,748.73 firm fixed-price purchase order to Novocure Inc. on October 30, 2025, for the rental of Optune Plus transducers. The contract, with an ultimate completion date of March 31, 2026, will be performed in Portsmouth, New Hampshire. Novocure Inc., a foreign-owned medical device manufacturer specializing in Tumor Treating Fields (TTFields) technology, will provide non-invasive cancer treatment...
- This federal contract award is for the delivery of Novocure Inc.'s Optune Plus transducers to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 firm-fixed-price purchase order was issued by the VA's VISN 7 network and has a performance period through March 31, 2025. Novocure, a foreign-owned, for-profit manufacturer of medical devices, is the prime contractor on this award. The contract does not utilize any set-aside designations. Novocure's Optune...
- Novocure Inc. was awarded a delivery order valued at $99,497.46 on October 20, 2025, by the Department of Veterans Affairs' Veterans Integrated Service Network 19 to supply Tumor Treating Fields (TTFields) medical devices and associated transducers for cancer treatment at a Portsmouth, New Hampshire facility. This firm fixed-price delivery order, which is scheduled for completion by December 24, 2025, represents a continuation of Novocure's ongoing provision of its FDA-approved Optune system...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price purchase order to Novocure Inc., a foreign-owned for-profit company, for the provision of Optune Plus Transducers. Novocure is the prime contractor and will deliver the medical equipment and services directly to the VA without subcontractors. The purchase order has a potential value of $126,000.00 and a period of performance ending on March 31, 2021. Novocure also holds a 5-year Federal Supply...
Novocure Inc. was awarded a $49,748.73 firm fixed-price purchase order by the Department of Veterans Affairs Veterans Integrated Service Network 20 on November 17, 2025, for custom Optune Plus transducers. The contract, with performance in Portsmouth, NH, is not set-aside designated and carries an ultimate completion date of November 16, 2026. This award represents a delivery order under Novocure's existing Federal Supply Schedule contract with the VA VHA for Medical Equipment and Supplies (FSS-65-II-A), valued at $28.85 million through October 31, 2027. Novocure serves as the prime contractor with no subcontractors involved. Novocure is a medical device manufacturer specializing in Tumor Treating Fields (TTFields) technology for treating solid tumors, including glioblastoma and mesothelioma, with FDA approval for both conditions. The company has established itself as a primary supplier of advanced cancer treatment technologies to VA medical centers nationwide, providing non-invasive medical devices and associated support services to veteran patients. The Optune system transducers covered under this purchase order support the VA's mission to expand access to cutting-edge cancer treatment options across its network of integrated service facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.7k | 11/20/25 |